Product and method for increasing uridine concentration in blood plasma

Product and method for increasing uridine concentration in blood plasma

The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue ava...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Hageman, Robert Johan Joseph
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Hageman, Robert Johan Joseph
description The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue availability of uridine, and/or for preventing/treating disorders associated with impaired blood plasma and tissue availability of uridine, in a mammal, preferably a human being, by orally co-administering soluble sodium and uridine in a molar ratio of soluble sodium to uridine of more than 1 : 1, preferably more than 1.5: 1, more preferably more than 2: 1, even more preferably at least 2.5: 1, even more preferably at least 2.8: 1, more preferably 3 : 1 - 15: 1, most preferably 3 : 1 - 10: 1, particularly 3 : 1 - 5: 1.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017314713A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017314713A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017314713A13</originalsourceid><addsrcrecordid>eNqNyz0KAjEQQOE0FqLeYcBaMEbYehF_SgutlzGZ1YHsTEiy9zeFB7B6zfeW5nrPGmZfASXARPWjAUbNwOIzYWF5w5w5sBB4FU9SM1ZWaQBeUZtOEcuEa7MYMRba_Loy28v5cbrtKOlAJWFbqQ7987C3nbPHzrreuv_UF0htNOM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Product and method for increasing uridine concentration in blood plasma</title><source>esp@cenet</source><creator>Hageman, Robert Johan Joseph</creator><creatorcontrib>Hageman, Robert Johan Joseph</creatorcontrib><description>The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue availability of uridine, and/or for preventing/treating disorders associated with impaired blood plasma and tissue availability of uridine, in a mammal, preferably a human being, by orally co-administering soluble sodium and uridine in a molar ratio of soluble sodium to uridine of more than 1 : 1, preferably more than 1.5: 1, more preferably more than 2: 1, even more preferably at least 2.5: 1, even more preferably at least 2.8: 1, more preferably 3 : 1 - 15: 1, most preferably 3 : 1 - 10: 1, particularly 3 : 1 - 5: 1.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190314&amp;DB=EPODOC&amp;CC=AU&amp;NR=2017314713A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190314&amp;DB=EPODOC&amp;CC=AU&amp;NR=2017314713A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hageman, Robert Johan Joseph</creatorcontrib><title>Product and method for increasing uridine concentration in blood plasma</title><description>The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue availability of uridine, and/or for preventing/treating disorders associated with impaired blood plasma and tissue availability of uridine, in a mammal, preferably a human being, by orally co-administering soluble sodium and uridine in a molar ratio of soluble sodium to uridine of more than 1 : 1, preferably more than 1.5: 1, more preferably more than 2: 1, even more preferably at least 2.5: 1, even more preferably at least 2.8: 1, more preferably 3 : 1 - 15: 1, most preferably 3 : 1 - 10: 1, particularly 3 : 1 - 5: 1.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyz0KAjEQQOE0FqLeYcBaMEbYehF_SgutlzGZ1YHsTEiy9zeFB7B6zfeW5nrPGmZfASXARPWjAUbNwOIzYWF5w5w5sBB4FU9SM1ZWaQBeUZtOEcuEa7MYMRba_Loy28v5cbrtKOlAJWFbqQ7987C3nbPHzrreuv_UF0htNOM</recordid><startdate>20190314</startdate><enddate>20190314</enddate><creator>Hageman, Robert Johan Joseph</creator><scope>EVB</scope></search><sort><creationdate>20190314</creationdate><title>Product and method for increasing uridine concentration in blood plasma</title><author>Hageman, Robert Johan Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017314713A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Hageman, Robert Johan Joseph</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hageman, Robert Johan Joseph</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Product and method for increasing uridine concentration in blood plasma</title><date>2019-03-14</date><risdate>2019</risdate><abstract>The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue availability of uridine, and/or for preventing/treating disorders associated with impaired blood plasma and tissue availability of uridine, in a mammal, preferably a human being, by orally co-administering soluble sodium and uridine in a molar ratio of soluble sodium to uridine of more than 1 : 1, preferably more than 1.5: 1, more preferably more than 2: 1, even more preferably at least 2.5: 1, even more preferably at least 2.8: 1, more preferably 3 : 1 - 15: 1, most preferably 3 : 1 - 10: 1, particularly 3 : 1 - 5: 1.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2017314713A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Product and method for increasing uridine concentration in blood plasma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A49%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hageman,%20Robert%20Johan%20Joseph&rft.date=2019-03-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017314713A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true